Get the Stockscreener App
17.47
1.42%
0.16
After Hours:
17.49
0.02
+0.11%
CryoLife, Inc. stock is traded at $17.47, with a volume of 9,543.
It is up +1.42% in the last 24 hours and down -11.27% over the past month.
CryoLife, Inc., together with its subsidiaries, manufactures, processes, and distributes medical devices and implantable human tissues for use in cardiac and vascular surgeries worldwide. The company operates in two segments, Medical Devices and Preservation Services. It offers BioGlue, an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X mechanical heart valves for aortic and mitral indications; cardiac preservation services; PhotoFix, a bovine pericardial patch for use in cardiac and vascular repairing activities; and PerClot, an absorbable powdered hemostat for use in surgical procedures, including cardiac, vascular, orthopedic, neurological, gynecological, ENT, and trauma surgeries. The company also provides cardiac laser therapy products, which include laser consoles, related service and maintenance, and single-use, as well as fiber-optic hand-pieces for the treatment of coronary artery disease in patients with severe angina. In addition, it distributes E-vita OPEN PLUS, a hybrid stent graft systems for the surgical and endovascular treatment; E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac, a stent graft used to treat aneurysmal iliac arteries, as well as aneurysmal iliac side branches; E-vita THORACIC 3G is a stent graft system for the endovascular treatment of thoracic aortic aneurysms; and E-tegra, an abdominal aortic aneurysms stent graft system for the endovascular treatment. Further, the company offers vascular preservation services; and synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures. The company serves physicians, hospitals, and other healthcare industries, as well as cardiac, vascular, thoracic, and general surgeons. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.
See More
Previous Close:
$17.63
Open:
$17.4
24h Volume:
9,543
Relative Volume:
66.00
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-56.35
EPS:
-0.31
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
-11.27%
6M Performance:
-32.91%
1Y Performance:
-25.93%
1-Day Range:
$17.35
$17.56
1-Week Range:
$17.35
$17.56
52-Week Range:
$17.35
$17.56
CryoLife, Inc. Stock (CRY) Company Profile
Name
CryoLife, Inc.
Sector
Industry
Phone
770-419-3355
Address
1655 Roberts Boulevard NW, Kennesaw
Compare CRY vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRY
CryoLife, Inc.
|
17.47 | 0 | 0 | 0 | 0 | 0.00 |
ABT
Abbott Laboratories
|
108.33 | 197.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.17 | 118.14B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
303.13 | 125.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
47.80 | 71.55B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.90 | 51.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
CryoLife, Inc. Stock (CRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-15-21 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-14-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-14-20 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Jan-29-20 | Reiterated | Needham | Buy |
| Dec-11-19 | Upgrade | Needham | Hold → Buy |
| Oct-22-19 | Initiated | Oppenheimer | Outperform |
| Feb-28-19 | Initiated | Needham | Hold |
| Feb-17-17 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Jan-09-17 | Initiated | Northland Capital | Outperform |
| Jun-15-16 | Initiated | Lake Street | Buy |
| Apr-28-16 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Apr-21-16 | Resumed | Piper Jaffray | Overweight |
| Apr-13-16 | Initiated | Canaccord Genuity | Buy |
| Aug-06-12 | Downgrade | The Benchmark Company | Buy → Hold |
| Apr-24-12 | Initiated | Ladenburg Thalmann | Buy |
| Jul-29-11 | Upgrade | The Benchmark Company | Hold → Buy |
| Apr-29-11 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-23-10 | Initiated | The Benchmark Company | Buy |
| Aug-01-08 | Reiterated | Jesup & Lamont | Buy |
| Aug-01-08 | Reiterated | Roth Capital | Buy |
| May-15-08 | Reiterated | Roth Capital | Buy |
View All
CryoLife, Inc. Stock (CRY) Latest News
Intel, Micron among mega-cap stock movers on Friday - Investing.com Nigeria
World Tissue Glue and Bio Adhesive SealantsMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Hemostasis & Tissue Sealing Agents Market Size, Share, Growth, 2034 - Straits Research
Micron, Qualcomm among market cap stock movers on Friday By Investing.com - Investing.com Nigeria
Intel, Micron among mega-cap stock movers on Friday By Investing.com - Investing.com Australia
Micron, Qualcomm among market cap stock movers on Friday - Investing.com UK
CRY ETF Price and Chart — NASDAQ:CRY - TradingView
Organ Preservation Market to Reach USD 466.23 Million by 2033 - openPR.com
Vascular Sealant Market Growth Fueled by Rising Cardiovascular Procedures Through 2035News and Statistics - IndexBox
Emerging Growth Patterns Driving Expansion in the Aortic Aneurysm Market - openPR.com
Artivion, Inc. (CYL.F) stock price, news, quote and history - Yahoo Finance UK
Cardiovascular And Soft Tissue Repair Patch Market Size, Share, Revenue Report 2026 to 2035 - Insightace Analytic
Transcatheter Heart Valve Replacement Market Size to Reach - GlobeNewswire
Thoracic Aortic Aneurysm Market | Global Market Analysis Report2035 - Fact.MR
Hemostatic Gels Market Size, Share, Growth | CAGR of 6.5% - Market.us
Transcatheter Heart Valve Replacement Devices Therapeutics: Global Innovation and Strategic Outlook to 2030 - blog.libero.it
Regenerative Medicine Market Research Report 2025 Featuring Stryker, Athersys, Integra Lifesciences, Isto Biologics, Organogenesis, CryoLife, Medtronic, U.S. Stem Cell, Zimmer Biomet, and 3M - orthospinenews.com
Laser Revascularization Method Could Help Where Bypasses Can’t | Features | Nov 2012 - Photonics Spectra
Barlow’s Syndrome Market | Global Market Analysis Report2035 - Future Market Insights
Structural Heart Devices Market Set to Expand and Reach - GlobeNewswire
Prosthetic Heart Valve Market Size | Industry Report, 2033 - Grand View Research
Aortic Valve Replacement Market Size, Share, Growth, Analysis, 2034 - Straits Research
Global Bone Cement & Glue Market Size, Top Share, Demand, Report to 2033 - Straits Research
$6.71 Bn Absorbable Hemostats Market Opportunities and - GlobeNewswire
$536.73 Bn Organ Preservation Solution Market Strategies - GlobeNewswire
Hutchinson Gilford Progeria Syndrome (HGPS) Therapeutics Market value of USD 233.05 Billion by regis - PharmiWeb.com
Organ and Tissue Transplantation Strategic Research Report - GlobeNewswire
CRY | GraniteShares YieldBOOST CRCL ETF Lobbying - Quiver Quantitative
Hemostats Market Size, Share & Growth Report, 2024-2030 - Grand View Research
Ronald D Mccall Net WorthInsider Trades and Bio as of Apr 23, 2026 - Benzinga
Soft Tissue Market Size, Share | CAGR Of 4.9% - Market.us
Heart Valves Companies - Market Research Future
CryoLife Hires CEO with Medtronic Experience - Medical Device and Diagnostic industry
Dermatology Lasers Market Thrives on Rising Incidences of Skin Cancer and Aesthetic Treatments - GlobeNewswire
Cardiac Sutures Global Market Report 2023 - GlobeNewswire
Birth Tissue Products Market Size, Industry Share, Forecast to 2034 - Fortune Business Insights
Biosurgery Market 2030: Production, Revenue, Growth Rate, Price and Gross Margin | Betatech, Hemostasis, - EIN News
Structural Heart Market Is Thriving Incredible Growth With - openPR.com
Aortic Aneurysm Market Size, Share | CAGR Of 10.8% - Market.us
Steven Anderson Obituary (2023)Sarasota, FLAtlanta Journal-Constitution - Legacy obituary
Steven Goodwin Anderson - Sarasota Herald-Tribune
A quick two step: Artivion granted PMA for Perclot, transfers it to Baxter for $18.75M - BioWorld News
Aortic Valve Replacement Market to Hit US$ 15.8 Billion, Globally, by 2027 at 11.59% CAGR - Digital Journal
Ms. Cheryl A. CobleView Obituary & Service Information - Northside Chapel Funeral Directors and Crematory
Global Aortic Valve Replacement Devices Market - Spherical Insights
Tissue and Organ Transplantation Market Size | CAGR Of 9.5% - Market.us
Tissue Transplantation Products and Services Market Generated - openPR.com
Vascular Graft Market is Anticipated to Grow at a CAGR of 6.38%, Assesses DelveInsight - PR Newswire
Global Organ Transplantation Software and Services Market - GlobeNewswire
CryoLife announces corporate rebrand, changes name to Artivion - MassDevice
Are CryoLife, Inc.'s (NYSE:CRY) Mixed Financials Driving The Negative Sentiment? - Yahoo Finance
CryoLife, Inc. Stock (CRY) Financials Data
There is no financial data for CryoLife, Inc. (CRY). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.86%
0.13%
Cap:
|
Volume (24h):